NCT00039988View on ClinicalTrials.gov

Treatment of Multiple Sclerosis With Copaxone and Albuterol

NACompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

November 30, 2001

Primary Completion Date

March 31, 2006

Study Completion Date

November 30, 2007

Conditions
Autoimmune DiseasesMultiple Sclerosis
Interventions
DRUG

Glatiramer acetate

20 mg administered subcutaneously daily

DRUG

Albuterol

2 mg or 4 mg oral capsules taken daily

DRUG

Albuterol placebo

Oral placebo capsules will be taken daily

Trial Locations (1)

02115

Brigham and Women's Hospital/Harvard Medical School, Boston

All Listed Sponsors
collaborator

Autoimmunity Centers of Excellence

OTHER

lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT00039988 - Treatment of Multiple Sclerosis With Copaxone and Albuterol | Biotech Hunter | Biotech Hunter